Funding and Research Partnerships

All of Us Research Program

Funding and Research Partnerships

Overview

Image
two women in lab coats at computer workstations in a clinical setting

The All of Us Research Program funds a broad portfolio of research partnerships, scientific collaborations, and grant opportunities. This page provides information on three types of funding engagement:

  • All of Us Funding Opportunities: Notice of Funding Opportunities (NOFOs), other transaction (OT) Research Opportunity Announcements (ROAs), and other mechanisms issued directly by the All of Us Research Program.
  • NIH Research Funding Opportunities: Grant mechanisms from NIH Institutes, Centers, and Offices that support research using the All of Us Researcher Workbench dataset.
  • Partnered Research Studies: Collaborative research opportunities (sometimes called ancillary studies) that expand the All of Us dataset through co-funded studies with NIH partners and others. 

For information about the organizations that carry out program operations, see Partners.

How Is All of Us Funded?

The All of Us Research Program (All of Us) is funded through annual federal appropriations from Congress. Since its creation under the 21st Century Cures Act in 2016, the Program has been supported through two primary funding sources: annual appropriations to the NIH Office of the Director and authorized funding from the Cures Innovation Fund for fiscal years (FYs) 2017 through 2026. Over its 10 years, the Cures Innovation Fund was instrumental in building the Program’s participant cohort, research infrastructure, and biobank. In FY 2027, the Program is projected to receive $122 million from annual appropriations, a nearly 80 percent decline from FY 2023 level as Cures funding ended.  

In addition to annual appropriations, in FY2026, All of Us received support through co-investments totaling approximately $106 million from multiple NIH Institutes and Centers and Offices along with two other federal agencies. These co-investments are being used to support scientific priorities across NIH by leveraging All of Us and its growing research resource. They enable partnered research studies through targeted enrollment and engagement of specific populations, new data collection and linkages, and biospecimen and genomic analyses that advance the missions of NIH Institutes, Centers, and Offices. These investments demonstrate the value of All of Us as an NIH-wide research platform, enabling new scientific opportunities that build on the Program’s foundational investments and capabilities.  

The annual appropriations, together with co-investments, provides essential support for the Program’s continued operations; it does not, however, represent a permanent nor full restoration of recent years’ funding reductions.  

The nearly 80 percent budget cut has led to reduced participant enrollment, scaled back data collection, and delayed our ability to build a robust pediatric cohort. The program has strategically focused available resources on preserving the existing participant relationships, bolstering data privacy and security, and protecting biospecimens, while continuing to support researchers who access the data and rely on All of Us to generate new findings. 

Image
Funding Chart - FY21 through FY27 expected appropriations.
Funding Chart - FY21 through FY27 expected appropriations.

Amidst these funding uncertainties, All of Us has enrolled more than 888,000 participants nationwide, with data from over 747,000 now available to researchers. This makes All of Us the largest integrated genomic and electronic health record database in the world. The resource is used by over 25,000 researchers from all 50 states, 1,500 registered institutions around the globe, and has produced more than 1,600 peer-reviewed publications, driving findings such as a new genetic test for inherited cardiovascular risk and an improved prostate cancer screening model now in clinical trials. All of Us serves as the nation’s precision medicine biobank and a cornerstone of NIH’s shared research infrastructure, providing a national platform accelerates research across diseases, reduces duplication and increases reproducibility, and creates biomedical research efficiencies.

All of Us Funding Opportunities

Image
two women at laptops in a conference room

The All of Us Research Program issues funding opportunities including notice of funding opportunities (NOFOs), other transaction (OT) research opportunity announcements (ROAs), and other mechanisms to advance program goals.

Current Funding Opportunities

All of Us funding opportunities are posted to the NIH Guide for Grants and Contracts, which is updated weekly. Sign up for email updates to be notified when new All of Us opportunities are posted.

Current Funding Opportunities

  • X01 Notice of Funding Opportunity: Accelerating Discovery Through Partnered Research with All of Us to Analyze Participant Biospecimens (PAR-27-069)
    Submission Due Dates:
    • July 01, 2026
    • October 30, 2026
    • March 01, 2027

Past Funding - For a directory of funded partners and their award vehicles, see the Partners page.

NIH Research Funding Opportunities

NIH Institutes, Centers, and Offices publish funding opportunities that support research using the All of Us Researcher Workbench dataset. These opportunities are listed in the NIH Guide for Grants and Contracts, which is updated weekly and available by free subscription.

Find current opportunities in the NIH Guide for Grants and Contracts.

Partnered Research Studies

All of Us works with NIH Institutes, Centers, and Offices and others on partnered research opportunities (sometimes called ancillary studies) that expand the All of Us dataset through co-funded studies. Current studies include Eyes on Health, Environmental Health and Exposomics, Exploring the Mind, and Nutrition for Precision Health.

Learn more about partnered research studies and how to propose a collaboration.

This page last reviewed on